Associations between glucocorticoid use and major adverse cardiovascular events in patients with prostate cancer receiving antiandrogen: a retrospective cohort study.

Jeffrey Shi Kai Chan Yan Hiu Athena Lee Steven Chi Ho LeungDavid Ka Wai LeungEdward Christopher DeeKenrick NgGary Tse Chi-Fai Ng

Published in: Prostate cancer and prostatic diseases (2024)

Prednisolone/prednisone coadministration with abiraterone likely contributed to abiraterone-related increased cardiovascular risk. Prevalent cumulative glucocorticoid dose was associated with cardiovascular risk.

Keyphrases

cardiovascular events
prostate cancer
coronary artery disease
cardiovascular disease
radical prostatectomy
emergency department